Imed Infinity Medical-Limited Partnership (TLV:IMED)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
121.50
+0.50 (0.41%)
Jun 4, 2026, 5:24 PM IDT
Market Cap4.88M +104.4%
Revenue (ttm)720.49K +451.2%
Net Income-612.10K
EPS-0.15
Shares Out 4.04M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume920
Open122.00
Previous Close121.00
Day's Range121.50 - 122.00
52-Week Range105.00 - 184.80
Beta0.25
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About TLV:IMED

Imed Infinity Medical-Limited Partnership engages in research and development and invests in projects in the medical field in Israel. The company’s products include Genoox, a platform for gathering genetic data; biobeat medical smartmonitoring, which provides wireless patient monitoring solutions for both clinical and at-home use; Polaris Quantum Biotech, a system for the computerized design of drugs using quantum computers; and Cynerio, which focuses on ensuring patient safety and data protection by securing the connected medical device ecosys... [Read more]

Sector Healthcare
Founded 2020
Employees 80
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol IMED
Full Company Profile

Financial Performance

In 2025, TLV:IMED's revenue was $226,000, an increase of 451.22% compared to the previous year's $41,000. Losses were -$192,000, -66.61% less than in 2024.

Financial numbers in USD Financial Statements